NCLT Sanctions Scheme of Amalgamation between JB Chemicals and Torrent Pharmaceuticals

NCLT Sanctions Scheme of Amalgamation between JB Chemicals and Torrent Pharmaceuticals

NCLT Sanctions Scheme of Amalgamation between JB Chemicals and Torrent Pharmaceuticals​

The National Company Law Tribunal (NCLT), Ahmedabad Bench, has sanctioned the Scheme of Amalgamation involving J. B. Chemicals & Pharmaceuticals Limited and Torrent Pharmaceuticals Limited.

J. B. Chemicals & Pharmaceuticals Limited has confirmed receiving the certified true copy of the order following the sanctioning by the NCLT. The Scheme involves the merger of J. B. Chemicals & Pharmaceuticals Limited, identified as the Transferor Company, with Torrent Pharmaceuticals Limited, identified as the Transferee Company, along with their respective shareholders.

The amalgamation process adheres to the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The Hon'ble NCLT issued its Order sanctioning the Scheme on July 6, 2026. J. B. Chemicals & Pharmaceuticals Limited confirmed receipt of the certified true copy of the order on July 7, 2026.

JBCHEPHARM Stock Price Movement​

Today, JB Chemicals & Pharmaceuticals Limited shares edged higher to close at ₹2422, posting a 1.26% gain after trading in the post-market session. The stock reached its 52-week high during this strong performance, which saw over 823,042 shares traded today.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top